ExteNET_2A: ExteNET, figure 2A

ExteNET_2AR Documentation

ExteNET, figure 2A

Description

Kaplan-Meier digitized data from ExteNET, figure 2A (PMID 26874901). A reported sample size of 2,840 for a primary endpoint of iDFS in breast cancer.

Usage

ExteNET_2A

Format

A data frame of 2,840 observations and 3 variables:

time event time (in months)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (neratinib, placebo)

Source

Chan A, Delaloge S, Holmes FA, et al. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2016; 17: 367–77.

Examples

summary(ExteNET_2A)

kmplot(ExteNET_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.